Flagship Pioneering, firm behind Moderna vaccine, re-opens Fund VII

The firm now plans to consolidate its two different fund series and is targeting $3bn in total commitments for Fund VII.

26 May 2021•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles